市場調查報告書
商品編碼
1368745
胃腸支架市場 - 按產品、按應用、材料、最終用途和預測,2023年至2032年Gastrointestinal Stents Market - By Product, By Application, By Material, By End-use, & Forecast, 2023 - 2032 |
2023年至2032年間,全球胃腸支架市場的年複合成長率將達到 5.2%。領先公司之間的合作和收購數量不斷增加,支持了市場成長。例如,2023年2月,Olympus出價3.7億美元收購Taewoong Medical,這是一家專門生產胃腸道手術內視鏡設備的韓國公司。Olympus在其公告中強調了 Taewoong 的各種金屬胃腸支架。這些支架在目的是緩解癌症或其他消化系統疾病等疾病引起的膽道、食道、結腸或十二指腸阻塞或狹窄的微創手術中發揮關鍵作用。
這些合作增強了研發能力,促進創新並擴大市場範圍。隨著公司聯合起來,他們利用綜合專業知識來開發先進的支架技術,增加需求並改善患者護理。這一趨勢重塑產業格局,推動胃腸支架市場成長。
整個胃腸支架市場根據產品、應用和地區進行分類。
食道支架細分市場從2023年到2032年將經歷重大發展。食道支架對於食道癌和食道狹窄等各種疾病的治療非常重要。它們的微創性質以及緩解吞嚥困難和預防併發症的有效性使其成為重要的醫療解決方案。胃腸道支架市場需求的不斷成長證明了它們對於改善食道問題患者的生活品質具有重要意義。
從2023年到2032年,大腸直腸癌細分市場將出現顯著的年複合成長率。結直腸支架提供了一種微創方法,可以緩解腫瘤引起的阻塞,促進排便並減輕疼痛。它們在安寧療護和作為手術橋樑方面的有效性導致了越來越多的採用。這表明結直腸支架在改善此類癌症患者的生活品質方面發揮關鍵作用,進一步鞏固了其在胃腸道支架市場成長中的作用。
歐洲胃腸道支架市場從2023年到2032年將呈現可觀的年複合成長率。人口老化和胃腸道疾病流行等因素推動了該成長。例如,根據歐洲聯合胃腸病學 (UEG) 報告,歐洲地區估計有超過 3.32 億消化系統疾病患者。此外,支架技術和微創手術的進步推動更高的採用率。歐洲對胃腸道支架的需求凸顯了它們在改善患者治療效果方面的作用以及該地區對醫療保健創新的承諾。
Global Gastrointestinal Stents Market will witness 5.2% CAGR between 2023 and 2032. The rising number of partnerships and acquisitions between leading companies supports market growth. For instance, in February 2023, Olympus put forth a bid of $370 million to acquire Taewoong Medical, a South Korean company specializing in the production of endoscopic devices for gastrointestinal procedures. Olympus highlighted Taewoong's extensive range of metallic gastrointestinal stents in their announcement. These stents play a pivotal role in minimally invasive procedures aimed at alleviating blockages or narrowing in the biliary tract, esophagus, colon, or duodenum caused by conditions such as cancer or other digestive system ailments.
These collaborations enhance research and development capabilities, foster innovation, and expand market reach. As companies join forces, they leverage combined expertise to develop advanced stent technologies, leading to increased demand and improved patient care. This trend is reshaping the industry landscape, driving progress in gastrointestinal stents market growth.
The overall Gastrointestinal Stents Market is classified based on product, application, and region.
Esophageal stents segment will undergo significant development from 2023 to 2032. Esophageal stents are crucial in the management of various conditions, such as esophageal cancer and strictures. Their minimally invasive nature and effectiveness in relieving dysphagia and preventing complications make them a vital medical solution. This growing gastrointestinal stents market demand supports their significance in improving the quality of life for patients with esophageal issues.
Colorectal cancer segment will register a noteworthy CAGR from 2023 to 2032. Colorectal stents offer a minimally invasive approach to relieve obstructions caused by tumors, facilitating bowel movements and reducing pain. Their effectiveness in palliative care and as a bridge to surgery has led to increased adoption. This demonstrates the pivotal role of colorectal stents in improving the quality of life for patients battling this type of cancer, further solidifying its role in the gastrointestinal stents market growth.
Europe gastrointestinal stents market will showcase an appreciable CAGR from 2023 to 2032. Factors like the aging population and the prevalence of gastrointestinal diseases are contributing to this growth. For instance, according to the United European Gastroenterology (UEG) reports, the European region is home to an estimated population of more than 332 million individuals with digestive disorders. Moreover, advancements in stent technology and minimally invasive procedures are driving higher adoption rates. The demand for gastrointestinal stents in Europe underscores their role in enhancing patient outcomes and the region's commitment to healthcare innovation.